| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia. | Neuropsychopharmacology | 2013 | 0.92 |
| 2 | Second-generation antipsychotics: reviewing the cost-effectiveness component of the CATIE trial. | Expert Rev Pharmacoecon Outcomes Res | 2007 | 0.84 |
| 3 | Relationships among neurocognition, symptoms and functioning in patients with schizophrenia: a path-analytic approach for associations at baseline and following 24 weeks of antipsychotic drug therapy. | BMC Psychiatry | 2009 | 0.83 |
| 4 | Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation. | Patient Prefer Adherence | 2012 | 0.75 |
| 5 | A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder. | Neuropsychopharmacology | 2016 | 0.75 |